Premium
Outcome and toxicity associated with a dose‐intensified, maintenance‐free CHOP‐based chemotherapy protocol in canine lymphoma: 130 cases
Author(s) -
Sorenmo K.,
Overley B.,
Krick E.,
Ferrara T.,
LaBlanc A.,
Shofer F.
Publication year - 2010
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/j.1476-5829.2010.00222.x
Subject(s) - canine lymphoma , medicine , toxicity , chop , lymphoma , stage (stratigraphy) , chemotherapy , incidence (geometry) , oncology , gastroenterology , surgery , biology , paleontology , physics , optics
A dose‐intensified/dose‐dense chemotherapy protocol for canine lymphoma was designed and implemented at the Veterinary Hospital of the University of Pennsylvania. In this study, we describe the clinical characteristics, prognostic factors, efficacy and toxicity in 130 dogs treated with this protocol. The majority of the dogs had advanced stage disease (63.1% stage V) and sub‐stage b (58.5%). The median time to progression (TTP) and lymphoma‐specific survival were 219 and 323 days, respectively. These results are similar to previous less dose‐intense protocols. Sub‐stage was a significant negative prognostic factor for survival. The incidence of toxicity was high; 53.9 and 45% of the dogs needed dose reductions and treatment delays, respectively. Dogs that required dose reductions and treatment delays had significantly longer TTP and lymphoma‐specific survival times. These results suggest that dose density is important, but likely relative, and needs to be adjusted according to the individual patient's toxicity for optimal outcome.